What did @sage_the_pixie actually say?
The creator's core argument is that gel users in the trans community get unfairly shamed, and that no testosterone delivery method is objectively superior for everyone. They specifically push back on claims that gel "doesn't work as well, it's not as safe, it's less effective, it's more expensive." This is a community-focused video, not a clinical one, and that context matters for how we evaluate it.
To their credit, they're not claiming gel is better than injections. They're arguing for individual choice and against method-shaming, which is a much easier position to defend scientifically. The caption also adds useful personal context: a needle phobia is a legitimate medical consideration, not a preference to be dismissed.
Does the science back this up?
Mostly, yes. The claim that gel is equally effective is supported, with important caveats. Studies show testosterone gels can achieve therapeutic serum levels comparable to injections when dosed correctly and applied consistently. A 2014 Cochrane review (Calof et al.) found no statistically significant differences in symptom resolution between transdermal and injectable testosterone in hypogonadal men. However, "equally effective" depends heavily on adherence, absorption variability, and skin transfer risk, none of which are minor asterisks.
The cost claim is more complicated. In the US market, branded testosterone gels (like AndroGel) are significantly more expensive than injectable testosterone cypionate without insurance. Generic gels have narrowed this gap, but it is not accurate to say cost is simply a matter of perspective. Injection users pointing to cost differences are often citing real numbers.
On safety, there is no strong evidence that gels are meaningfully less safe than injections for most users. The risks are different, not ranked.
What did they get wrong (or right)?
They got the big picture right. There is genuine clinical support for gel as a legitimate, effective delivery method. The framing that "they will all have different advantages and disadvantages" is textbook accurate and reflects actual endocrinology guidelines. The Endocrine Society's 2017 clinical practice guidelines for transgender individuals explicitly list gels, patches, and injections as acceptable options without ranking them.
Where they were imprecise: saying gel users are told it "doesn't work as well" and implying that's simply wrong leaves out a real nuance. Injections, particularly testosterone cypionate or enanthate, do tend to produce higher peak serum testosterone levels than gels, which some users find clinically meaningful. For people trying to achieve certain masculinization outcomes, this difference can matter. Saying "they all work the same" would be inaccurate. Saying "the right option depends on the individual" is accurate.
The cost criticism directed at gel is not entirely unfair, and dismissing it wholesale does a disservice to people navigating tight budgets.
What should you actually know?
If you are choosing a testosterone delivery method, the relevant variables are your individual pharmacokinetics, your lifestyle, your ability to adhere to a regimen, any phobias or physical limitations, and what your prescribing clinician recommends based on your labs and goals. That is not a cop-out answer. It is what the evidence actually supports.
Gel absorption varies significantly between individuals. A 2008 study by Steidle et al. in the Journal of Clinical Endocrinology found absorption rates for topical testosterone varied by as much as 40% between subjects using the same dose. This means two people on identical gel prescriptions can end up with very different serum levels. Regular lab monitoring is not optional with any delivery method, but this variability makes it especially important with gels.
Skin transfer to partners or children is a real safety concern with gels that injections do not carry. This is not a reason to avoid gel, but it is a reason to apply it carefully and let it dry completely before skin contact. The FDA has issued warnings on this specific risk.
The creator's point about needle phobia deserves more credit than it usually gets in clinical discussions. Needle phobia affects an estimated 25% of adults (Taddio et al., 2012, Clinical Journal of Pain) and is a documented barrier to injection-based therapies. Choosing gel for this reason is not weakness; it is harm reduction in a very practical sense.